Bromelain Market Poised for Steady Growth, Driven by Healthcare Applications and Demand for High-Strength Enzyme Products
-
Global bromelain market valued at $27.3 million in 2024, projected to reach $56.2 million by 2034 at a 7.5% CAGR
-
Powdered bromelain widely used for its flexibility in controlling concentration and dosage
-
Bromelain with high enzyme strength to account for 44.6% market share by 2034
-
Healthcare segment to capture 53.2% revenue share owing to anti-inflammatory and therapeutic properties
-
North America to contribute 22.1% to global revenue in 2024, while sales in Japan to rise at 7.2% CAGR